CDK4/6 inhibition triggers ICAM1-driven immune response and sensitizes LKB1 mutant lung cancer to immunotherapy.
Bai X, Guo ZQ, Zhang YP, Fan ZZ, Liu LJ, Liu L, Long LL, Ma SC, Wang J, Fang Y, Tang XR, Zeng YJ, Pan X, Wu DH, Dong ZY.
Bai X, et al. Among authors: fan zz.
Nat Commun. 2023 Mar 4;14(1):1247. doi: 10.1038/s41467-023-36892-4.
Nat Commun. 2023.
PMID: 36871040
Free PMC article.